Home › Research › Topics › non-demented
non-demented
4 studies tagged non-demented, dated 2021-06-14 to 2024-07-05. Bibliography: BibTeX (.bib) · RIS (.ris)
Newest in this topic
- Longitudinal plasma phosphorylated-tau217 and other related biomarkers in a non-demented Alzheimer's risk-enhanced sample 2024-07-05
- Comparison of plasma and neuroimaging biomarkers to predict cognitive decline in non-demented memory clinic patients 2024-05-16
- Amyloid-β levels and cognitive trajectories in non-demented pTau181-positive subjects without amyloidopathy 2022-11-01
Studies
4 studies carry this tag.
Date range
2021 to 2024
Top journals
- Alzheimer's & dementia : the journal of the Alzheimer's Association 1
- Alzheimer's research & therapy 1
- Brain : a journal of neurology 1
- Brain communications 1
Newest first, then by address. Each study has a usefulness score out of 100 (rubric version 4.0); tap a score to see what makes it up. Tags were assigned automatically from each study's title and summary. The same studies as a filter in the library.
-
In the CU, amyloid-negative (A-) subset, plasma p-tau217 levels increased modestly with age but were unaffected by body mass index and kidney function.
-
Plasma NfL and GFAP predict cognitive decline in a similar manner to traditional imaging techniques in amyloid-positive MCI patients.
-
Phosphorylated Tau181 (pTau181) in CSF and recently in plasma has been associated with Alzheimer's disease.
-
Mixed-effect models assessed rates of memory decline in relation to baseline plasma p-tau181, and whether plasma p-tau181 significantly predicted memory decline beyond widely available clinical and genetic data (age, sex, years of education, cardiovascular and metabolic conditions, and APOE ε 4 status).